Drug Database
IN

insulin (Oralgen, Generex / insulin, RapidMist / Oralgen)

✓ Approved

Eli Lilly · INSR · 多肽类

什么是 insulin?

insulin 是一种多肽类,由Eli Lilly研发。该药已获批,用于治疗相关适应症,给药途径:Oral (PO)、Sublingual (SL)/Oral Transmucosal。

药物档案

商品名Oralgen, Generex, insulin, RapidMist, Oralgen
公司Eli Lilly
药物类别多肽类
分子靶点INSR
给药途径Oral (PO), Sublingual (SL)/Oral Transmucosal
状态Approved

作用机制

分子靶点

insulin 作用于 1 个分子靶点:

INSRinsulin receptor (CD220, HHF5)
需要更深入的分析?Noah AI 可解释复杂机制并与同类药物比较。

治疗适应症

insulin 针对 3 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Metabolism and nutrition disordersType 1 diabetes mellitus✓ Approved
Metabolism and nutrition disordersType 2 diabetes mellitus✓ Approved
Metabolism and nutrition disordersGlucose tolerance impairedPhase II

相关研究文献

PubMedJournal of forensic sciences2026-11-17

Alcohol consumption is associated with increased prediction error in a buccal swab-based DNA methylation age prediction model.

Keskin Nursena N, Ersoy Gokhan G, Sımsek Sumeyye Zulal SZ, Can Kadriye K et al.

DNA methylation (DNAm)-based age estimation is a promising forensic tool, but prediction accuracy may be affected by lifestyle factors such as alcohol consumption. This study evaluated a buccal swab DNAm age prediction model, developed in non-drinking individuals, when applied to individuals with varying drinking patterns. Buccal swabs were collected from 90 healthy non-drinkers (mean age 44.9 years; range 22-93) for model development and from 62 regular alcohol consumers (mean age 32.8 years; range 19-63), classified as light (n = 29), moderate (n = 21), or heavy (n = 12) drinkers per NIAAA criteria, for model evaluation. Stepwise multivariate linear regression across seven candidate age-associated CpG loci identified a 3-CpG model (SLC12A5, ASPA, FHL2) explaining 61% of age variance (adjusted R2 = 0.613; MAE = 7.7 years; r = 0.791, p < 0.001). When applied to the alcohol-consuming cohort, prediction error increased significantly (MAE = 9.9 years; p = 0.046), with light and heavy drinkers showing markedly elevated error while moderate drinkers did not differ from non-drinkers. The association remained significant after adjusting for smoking status and chronological age. An extended model incorporating alcohol consumption as a predictor, retrained on the combined cohort (n = 152), achieved comparable accuracy (adjusted R2 = 0.605; MAE = 7.4 years) and retained alcohol consumption as a significant negative predictor of age (B = -6.84, p < 0.001). At the locus level, ASPA's age association was attenuated in alcohol consumers, whereas FHL2 and SLC12A5 showed no significant alcohol interaction. As lifestyle data are usually unavailable in casework, alcohol-robust CpG sites should be prioritized in forensic model development.

PMID 43040784
阅读全文 →
PubMedBMC oral health2026-11-17

Radiological analysis of lingual mandibular bone depression: morphological classification and anatomical relationships in large sample study.

Jeon Ye Rim YR, Kang In Sik IS, Jeon Kug Jin KJ, Lee Chena C et al.

This study aims to comprehensively characterize the clinical and radiographic features of lingual mandibular bone depression (LMBD), a frequently misdiagnosed yet benign mandibular entity. Particular emphasis is placed on atypical presentations that deviate from classical descriptions and challenge conventional diagnostic assumptions. We analyzed panoramic radiographs and three-dimensional images from 223 cases diagnosed with LMBD. On panoramic radiographs, we evaluated the anatomical location and the relationship with adjacent teeth and the mandibular canal. Three-dimensional imaging was used to evaluate the relationships with adjacent teeth and the mandibular canal, as well as buccal cortical bone involvement. Chi-square goodness-of-fit tests were used to assess differences in the distributions of sex and lesion side, with statistical significance set at p < 0.05. LMBDs were more frequently observed in male patients (79.37%) and in patients aged 50 years or older (60.54%), with a significant difference in sex distribution. The lesions were observed on the left side in 113 cases (50.67%) and on the right side in 110 cases (49.33%), with no statistically significant difference. The angle area was the most common location (53.36%). Contact with adjacent teeth was identified in 8.07% of cases on panoramic radiographs and in 6.73% on three-dimensional imaging, and 48.88% of cases were in contact with the mandibular canal. Class 2 buccal cortical involvement was frequently observed (48.88%). Three cases were radiographically absent in earlier imaging but became apparent in adulthood, and five cases showed progressive enlargement over several years. This study demonstrates that LMBDs exhibit a broader anatomical spectrum than previously recognized in terms of lesion location, anatomical relationships, and buccal cortical bone involvement. It particularly demonstrates that atypical LMBD cases with a high potential for misdiagnosis are not uncommon. These findings emphasize the clinical importance of recognizing atypical LMBDs and assessing their anatomical relationships through 3D imaging to achieve accurate differential diagnosis. Not applicable.

PMID 43040286
阅读全文 →
PubMedDrugs2026-11-17

Insulin Efsitora Alfa: First Approval.

Blair Hannah A HA

Insulin efsitora alfa (Onswik™) is a once-weekly ultra-long-acting recombinant basal insulin being developed by Eli Lilly and Company for the treatment of diabetes mellitus. Administered once weekly as a subcutaneous injection, insulin efsitora alfa is designed to provide a simplified treatment regimen relative to standard daily basal insulins. On 20 August 2026, insulin efsitora alfa received its first approval in the EU for the treatment of type 2 diabetes mellitus (T2DM) in adults. On 24 September 2026, insulin efsitora alfa was approved in the USA as an adjunct to diet and exercise to improve glycemic control in adults with T2DM. Insulin efsitora alfa is approved in the EU, Iceland, Norway, Liechtenstein and the USA and is under regulatory review in the UK and Japan for T2DM. This article summarizes the milestones in the development of insulin efsitora alfa leading to this first approval for T2DM.

PMID 43040187
阅读全文 →
PubMedNature metabolism2026-11-17

Plasma proteomics identifies insulin resistance signatures predictive of cardiometabolic disease risk.

Kjærgaard Jeppe J, Kurgan Nigel N, Gräf Justus F JF, Zhang Naixin N et al.

Insulin resistance drives cardiometabolic disease, yet its molecular signatures and tissue origins remain incompletely characterized. Here we define a circulating protein signature that enables scalable assessment of insulin sensitivity. We applied multiworkflow proteomics to plasma from 161 individuals spanning the insulin sensitivity spectrum defined by the hyperinsulinaemic-euglycaemic clamp and identified 488 proteins associated with insulin sensitivity, capturing contributions from liver, adipose tissue and immune cells. A subset of these proteins shifted towards a more insulin-sensitive profile following an exercise intervention in men. We further developed a model combining 13 proteins, including IGFBP1, LEP, GDF15, PON3 and LDLR, with clinical variables (sex, HbA1c and the triglyceride-to-high-density lipoprotein cholesterol ratio) to predict insulin sensitivity (R2 = 0.67). In ~20,000 UK Biobank participants, the model outperformed the triglyceride-to-high-density lipoprotein cholesterol ratio in predicting type 2 diabetes (concordance index, 0.86 versus 0.74) and, unlike HbA1c, predicted hepatic, renal, cardiovascular and respiratory disease. In an independent cohort of 1,700 individuals, the model also showed greater predictive utility than fasting insulin resistance indices, including the homeostatic model assessment of insulin resistance. Together, these findings establish a tissue-resolved plasma proteomic framework for characterizing insulin resistance and provide a scalable approach to precision cardiometabolic risk stratification.

PMID 43040099
阅读全文 →
PubMedBMC biology2026-11-17

Drosophila CerS homeodomain sites differentially alter insulin resistance.

Vera-Granda Christian C, Sociale Mariangela M, Beckschäfer Konstantin K, Kanevskij Ilja I et al.

Ceramides are central sphingolipid intermediates whose abundance and molecular composition are closely linked to insulin resistance. Ceramide synthases (CerSs) generate ceramides and, in several family members, also contain a conserved homeodomain with poorly understood metabolic functions. Drosophila has a single CerS, Schlank, which contains a catalytic Lag1p motif and two predicted nuclear localization sequences, NLS1 and NLS2. We investigated how distinct Schlank homeodomain mutations affect high-sugar diet (HSD)-induced insulin resistance. Endogenous KINLS1 and KIE118A knock-in alleles retained DNA binding and transcriptional repression under basal conditions but increased susceptibility to HSD-induced metabolic dysfunction. Both mutants developed enhanced hyperglycemia and impaired insulin-responsive tGPH recruitment, while KIE118A additionally showed increased FoxO nuclear localization and DILP2 retention in insulin-producing cells. By contrast, fat-body-specific switching to the DNA-binding-deficient NLS2 variant or the catalytically inactive H215D variant attenuated selected HSD-induced phenotypes, including FoxO nuclear accumulation and DILP2 retention, without fully correcting hyperglycemia or reduced body weight. Lipidomic analysis revealed extensive diet-dependent sphingolipid remodeling. In particular, NLS2 and H215D markedly reduced the fat-body ceramide pool, including abundant d14:1/20:0- and d14:1/22:0-containing Cer, CerPE, and HexCer species. The Schlank homeodomain regulates insulin homeostasis in a site- and tissue-dependent manner. Distinct homeodomain mutations can either increase susceptibility to or partially attenuate HSD-induced insulin resistance, potentially involving insulin signaling, inter-organ communication, and sphingolipid composition.

PMID 43040328
阅读全文 →
PubMedEuropean journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)2026-11-17

Healthy lifestyle adherence and insulin resistance in prostate cancer patients undergoing radiotherapy: baseline findings from the MicroStyle study.

Doi Giulia G, Bellerba Federica F, Repetti Ilaria I, Mazzocco Ketti K et al.

Radiotherapy in prostate cancer (PCa) may induce side effects and reduced quality of life (QoL). Diet and physical activity may improve prognosis and treatment outcomes, potentially through modulation of insulin resistance. The aim of this cross-sectional subanalysis of the MicroStyle trial is to investigate the association of adherence to a healthy lifestyle with insulin resistance in PCa patients before radiotherapy, and to study the interrelations between lifestyle adherence, insulin resistance, hormonal biomarkers, inflammatory, and psychosocial variables. Insulin resistance was measured via Homeostasis Model Assessment of Insulin Resistance (HOMA-IR). Lifestyle adherence was quantified using the World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) score, and participants were classified as adherent if they had a WCRF/AICR score above the cohort median. Associations between WCRF/AICR adherence, HOMA-IR, biomarkers, and psychosocial factors were evaluated using univariate and multivariable logistic regression, supported by network analysis. Baseline adherence to WCRF/AICR recommendations was independently associated with lower HOMA-IR, with approximately 60% significantly lower odds of insulin resistance (odds ratio = 0.39, 95% confidence interval: 0.22-0.67). Higher HOMA-IR was observed in patients on hormone therapy (P < 0.001) and those with a stronger tendency to control others (P = 0.02), adjusting for sex hormone-binding globulin (P < 0.001) and adiponectin (P = 0.01), which emerged as significant biomarkers. This study revealed clear associations between lifestyle, metabolic health, and psychological factors. Promoting a healthy lifestyle and psychological support in PCa patients may improve metabolic health.

PMID 43040935
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多insulin